C07F 9/65038
Condensed with carbocyclic rings or carbocyclic ring systems
Official title: {condensed with carbocyclic rings or carbocyclic ring systems}
C07F9/65038 (Condensed with carbocyclic rings or carbocyclic ring systems) appears on 35 US grants and 32 published applications in this corpus.
Search patents in C07F- Granted patents
- 35
- Published applications
- 32
- Assignees
- 25
- Inventors
- 168
- Latest grant
- 10 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 3 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 2 | 4 |
| 2008 | 3 | 2 |
| 2009 | 3 | 1 |
| 2010 | 2 | 4 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 3 |
| 2015 | 3 | 0 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 3 |
| 2023 | 2 | 1 |
| 2024 | 2 | 0 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Therapeutic compounds for HIV virus infection10 Sep 2024US 12,084,467 B2Gilead Sciences, Inc.
- Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors9 Jul 2024US 12,029,744 B2Riboscience LLC
- Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors5 Dec 2023US 11,834,467 B21ST Biotherapeutics, Inc.
- Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same16 May 2023US 11,649,255 B21ST Biotherapeutics, Inc.
- Mito-lonidamine, compositions and methods of use7 Jun 2022US 11,352,382 B2Aix-Marseille Universite
- Phosphorus compound and use thereof2 Oct 2025US 2025/0304608 A1Shanghai Shijiang Biotechnology Co., Ltd
- Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors6 Feb 2025US 2025/0041319 A1Riboscience LLC
- Therapeutic compounds for hiv virus infection29 Jun 2023US 2023/0203071 A1Gilead Sciences, Inc.
- Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors17 Nov 2022US 2022/0362266 A1Riboscience LLC
- Indazoles as hematopoietic progenitor kinase 1 (hpk1) inhibitors and methods using same31 Mar 2022US 2022/0098193 A11ST Biotherapeutics, Inc.
Most cited
By later US patents
- Organophosphorus derivatives of indazoles and use thereof as medicinal products90US 7,491,710 B2Aventis Pharma S. A. · 2009
- Phosphonic acid derivatives65US 5,719,303 AEisai Co., Ltd. · 1998
- Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus50US 8,211,923 B2Boehringer Ingelheim International GmbH · 2012
- Method for the separation of acids from chemical reaction mixtures by means of ionic fluids34US 7,351,339 B2BASF SE · 2008
- Phosphate linked oligomers29US 5,886,177 AIsis Pharmaceuticals, Inc. · 1999